Characterization of Neurokinin Effects and Receptor Selectivity in Human Isolated Bronchi
- 31 August 1989
- journal article
- research article
- Published by American Thoracic Society in American Review of Respiratory Disease
- Vol. 140 (3) , 679-686
- https://doi.org/10.1164/ajrccm/140.3.679
Abstract
Sensitive afferent nerves and the neurokinins they release upon activation are considered to be important in controlling bronchomotor tone. Human isolated bronchi espond to neurokinin A (NKA) substance P (SP), and neurokinin B (NKB) with dose-dependent contractions. The ordier of potency of the three natural neurokinins is NKA > SP > NKB, usggesting the presence of NK-2 receptors. To further characterize the neurokinin receptors in human bronchi, we used selective agonists for each receptor type (i.e., NK-1, NK-2, and NK-3). In fact, NK-1 selective compounds, [Pro9]SP(1-11) sulfone and [.beta.-Ala4,Sar9]SP(4-11) sulfone, did not induce significant contractions up to 10-5 M. Similarly, the selective agonist for the NK-3 receptor, [MePhe7]NKB(4-10), was almost inactive. However, the NK-2 selective fragment [Nle10]NKA(4-10) was a potent stimulant. The negative log of the peptide concentration that caused 50% of maximal effect (pD2) was 6.99 for NKA and 6.12 for [Nle10]NKA(4-10). Removal of the epithelium significantly enhanced the contractile responses to the three neurokinins and also to the NK-2 selective agonist. Phosphoramidon an enkephalinase inhibitor, was more potent than epithelium removal in enhancing the contractile responses to these agonists. However, epithelium removal and phosphoramidon did not increase the weak response to the NK-1 and NK-3 selective compounds. In the presence of phosphoramidon, removal of the epithelium slightly enhanced the contractile responses to NKA and [Nle10]NKA(4-10) but not to SP and NKB. These results suggest that in human bronchi (1) the receptors involved in the neurokinin-induced contractions belong to the NK-2 type, (2) the epithelium exerts an inhibitory effect on these contractions, (3) bronchial enkephalinase is an important modulator of neurokinin-induced effects, and (4) the epithelial inhibitory effect could be attributed in part to an enkephalinase activity.This publication has 49 references indexed in Scilit:
- Comparison of the effects of epithelium removal and of an enkephalinase inhibitor on the neurokinin‐induced contractions of guinea‐pig isolated tracheaBritish Journal of Pharmacology, 1988
- Tools for tachykinin and neuropeptide research: A conference reportNeuroscience Letters, 1988
- Comparison of neurokinin A and substance P on cardiovascular and airway function in man.British Journal of Clinical Pharmacology, 1988
- Effect of inhaled substance P and neurokinin A on the airways of normal and asthmatic subjects.Thorax, 1987
- Neurokinin A as a Potent BronchoconstrictorAmerican Review of Respiratory Disease, 1987
- Demonstration of the release of an epithelium-derived inhibitory factor from a novel preparation of guinea-pig tracheaEuropean Journal of Pharmacology, 1987
- Airway epithelium releases a relaxant factor: demonstration with substance PEuropean Journal of Pharmacology, 1986
- The influence of epithelium on the responsiveness of guinea‐pig isolated tracheaBritish Journal of Pharmacology, 1986
- Comparison of cardiovascular and bronchoconstrictor effects of substance P, substance K and other tachykininsNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1984
- The metabolism of neuropeptides. The hydrolysis of peptides, including enkephalins, tachykinins and their analogues, by endopeptidase-24.11Biochemical Journal, 1984